Posterior Fossa Dural Arteriovenous Fistulas with Subarachnoid Venous Drainage: Outcomes of Endovascular Treatment.


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
08 2019
Historique:
received: 19 04 2019
accepted: 19 06 2019
pubmed: 3 8 2019
medline: 7 5 2020
entrez: 3 8 2019
Statut: ppublish

Résumé

Dural AVFs located in the posterior fossa are a rare entity. The objectives of the study were to analyze the anatomy of dural AVFs, their endovascular treatment strategies, and clinical outcomes. Two centers retrospectively selected patients treated between January 2009 and June 2018 having posterior fossa dural AVFs. We collected patient demographics, clinical presentation, arterial and venous outflow anatomy of the dural AVFs, and treatment outcomes. Twenty-six patients treated endovascularly for posterior fossa dural AVFs, type III, IV, or V, were included. One hundred percent of the dural AVFs were occluded. A transarterial approach was performed in 23 dural AVFs (88.5%); a combined transarterial and transvenous approach, for 2 dural AVFs (7.7%); and a transvenous approach alone, for 1 dural AVF (3.8%). The middle meningeal artery was the most common artery chosen to inject embolic liquid (46%, 12/26). Procedure-related morbidity was 15.4% at 24 hours, 7.7% at discharge, and 0% at 6 months. Procedure-related mortality was 0%. Endovascular treatment offers high occlusion rates for posterior fossa dural AVFs with low morbidity and mortality rates. The arterial approach is the first-line preferred approach, even if a transvenous or combined approach would be a safe and effective option for patients with favorable anatomy.

Sections du résumé

BACKGROUND AND PURPOSE
Dural AVFs located in the posterior fossa are a rare entity. The objectives of the study were to analyze the anatomy of dural AVFs, their endovascular treatment strategies, and clinical outcomes.
MATERIALS AND METHODS
Two centers retrospectively selected patients treated between January 2009 and June 2018 having posterior fossa dural AVFs. We collected patient demographics, clinical presentation, arterial and venous outflow anatomy of the dural AVFs, and treatment outcomes.
RESULTS
Twenty-six patients treated endovascularly for posterior fossa dural AVFs, type III, IV, or V, were included. One hundred percent of the dural AVFs were occluded. A transarterial approach was performed in 23 dural AVFs (88.5%); a combined transarterial and transvenous approach, for 2 dural AVFs (7.7%); and a transvenous approach alone, for 1 dural AVF (3.8%). The middle meningeal artery was the most common artery chosen to inject embolic liquid (46%, 12/26). Procedure-related morbidity was 15.4% at 24 hours, 7.7% at discharge, and 0% at 6 months. Procedure-related mortality was 0%.
CONCLUSIONS
Endovascular treatment offers high occlusion rates for posterior fossa dural AVFs with low morbidity and mortality rates. The arterial approach is the first-line preferred approach, even if a transvenous or combined approach would be a safe and effective option for patients with favorable anatomy.

Identifiants

pubmed: 31371356
pii: ajnr.A6140
doi: 10.3174/ajnr.A6140
pmc: PMC7048494
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1363-1368

Informations de copyright

© 2019 by American Journal of Neuroradiology.

Références

J Neuroradiol. 2013 May;40(2):134-9
pubmed: 23433906
Neurosurgery. 2008 Mar;62(3 Suppl 1):110-24; discussion 124-5
pubmed: 18424975
Acta Neurochir (Wien). 2007;149(9):929-35; discussion 935-6
pubmed: 17700989
AJNR Am J Neuroradiol. 2008 Feb;29(2):235-41
pubmed: 17989374
Neurosurgery. 2009 Dec;65(6 Suppl):132-9; discussion 139-40
pubmed: 19934987
Oper Neurosurg (Hagerstown). 2018 Sep 1;15(3):262-269
pubmed: 29126165
J Neurointerv Surg. 2017 May;9(5):516-523
pubmed: 26614491
J Neurosurg. 1986 May;64(5):724-30
pubmed: 3701421
Neurosurgery. 2014 Jun;10 Suppl 2:357-67; discussion 367
pubmed: 24561869
AJNR Am J Neuroradiol. 1992 Jan-Feb;13(1):315-23
pubmed: 1595468
Radiology. 1968 Jan;90(1):27-35
pubmed: 5635134
Surg Neurol. 2007 May;67(5):472-81; discussion 481-2
pubmed: 17445607
Radiology. 1969 Nov;93(5):1071-8
pubmed: 5350675
AJNR Am J Neuroradiol. 2013 Sep;34(9):1798-804
pubmed: 23660293
World Neurosurg. 2018 Nov;119:e968-e976
pubmed: 30103057
Radiology. 1995 Mar;194(3):671-80
pubmed: 7862961
Radiology. 1972 Oct;105(1):55-64
pubmed: 5057316
Interv Neuroradiol. 2017 Dec;23(6):661-665
pubmed: 28975855
AJNR Am J Neuroradiol. 2011 Dec;32(11):2180-4
pubmed: 21998110

Auteurs

L Détraz (L)

From the Service de Neuroradiologie Interventionnelle et Diagnostique (L.D.), Centre Hospitalier Universitaire de Nantes-Hopital Laennec, Saint-Herblain, France lili.detraz@gmail.com.

K Orlov (K)

Department of Neurosurgery (K.O., V. Berestov), E. Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation, Novosibirsk, Russia.

V Berestov (V)

Department of Neurosurgery (K.O., V. Berestov), E. Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation, Novosibirsk, Russia.

V Borodetsky (V)

Service de Radiologie (V. Borodetsky, A.R.. L.G.d.A.M., C.M.), Neuroradiologie Interventionnelle, Centre Hospitalier Universitaire de Limoges, Limoges, France.

A Rouchaud (A)

Service de Radiologie (V. Borodetsky, A.R.. L.G.d.A.M., C.M.), Neuroradiologie Interventionnelle, Centre Hospitalier Universitaire de Limoges, Limoges, France.
CNRS (A.R., C.M.), XLIM, UMR 7252, University of Limoges, Limoges, France.

L G de Abreu Mattos (LG)

Service de Radiologie (V. Borodetsky, A.R.. L.G.d.A.M., C.M.), Neuroradiologie Interventionnelle, Centre Hospitalier Universitaire de Limoges, Limoges, France.

C Mounayer (C)

Service de Radiologie (V. Borodetsky, A.R.. L.G.d.A.M., C.M.), Neuroradiologie Interventionnelle, Centre Hospitalier Universitaire de Limoges, Limoges, France.
CNRS (A.R., C.M.), XLIM, UMR 7252, University of Limoges, Limoges, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH